Traditionally, user fee negotiations, whether for PDUFA, GDUFA or BSUFA, have maintained that the negotiations are essentially for fee-for-service contracts. What this means is that the industry provides fees and the FDA provides services for those fees. The negotiations usually end with the commitment letter and any statutory changes that result from the negotiations. For […]